58.64
price down icon2.36%   -1.42
after-market Dopo l'orario di chiusura: 60.00 1.36 +2.32%
loading
Precedente Chiudi:
$60.06
Aprire:
$59.87
Volume 24 ore:
1.14M
Relative Volume:
1.24
Capitalizzazione di mercato:
$3.24B
Reddito:
$249.12M
Utile/perdita netta:
$-90.19M
Rapporto P/E:
-34.49
EPS:
-1.7
Flusso di cassa netto:
$-88.21M
1 W Prestazione:
-0.49%
1M Prestazione:
-0.49%
6M Prestazione:
-20.17%
1 anno Prestazione:
-13.06%
Intervallo 1D:
Value
$57.90
$60.57
Intervallo di 1 settimana:
Value
$55.76
$62.17
Portata 52W:
Value
$47.04
$103.81

Procept Biorobotics Corp Stock (PRCT) Company Profile

Name
Nome
Procept Biorobotics Corp
Name
Telefono
(650) 232-9832
Name
Indirizzo
150 BAYTECH DRIVE, SAN JOSE
Name
Dipendente
756
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-28
Name
Ultimi documenti SEC
Name
PRCT's Discussions on Twitter

Confronta PRCT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
PRCT
Procept Biorobotics Corp
58.64 3.32B 249.12M -90.19M -88.21M -1.70
Medical Devices icon
ABT
Abbott Laboratories
125.64 218.92B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.21 152.62B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
396.66 153.22B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
92.32 117.89B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
75.80 45.12B 5.54B 4.18B 623.10M 7.00

Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-09 Iniziato Stephens Overweight
2025-07-07 Iniziato Oppenheimer Perform
2024-12-02 Iniziato Morgan Stanley Overweight
2024-11-14 Iniziato Jefferies Hold
2023-08-11 Iniziato Piper Sandler Overweight
2023-05-31 Iniziato William Blair Outperform
2022-10-31 Iniziato BTIG Research Neutral
2022-10-25 Iniziato Truist Buy
2022-09-02 Iniziato Wells Fargo Overweight
2022-07-15 Iniziato KeyBanc Capital Markets Overweight
2022-06-23 Iniziato B. Riley Securities Buy
2021-10-11 Iniziato BofA Securities Buy
2021-10-11 Iniziato Cowen Outperform
2021-10-11 Iniziato Goldman Neutral
2021-10-11 Iniziato Guggenheim Buy
2021-10-11 Iniziato SVB Leerink Outperform
Mostra tutto

Procept Biorobotics Corp Borsa (PRCT) Ultime notizie

pulisher
Jul 24, 2025

PROCEPT BioRobotics: Promising Growth Under New Leadership and Attractive Valuation - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

Larry Wood to join PROCEPT BioRobotics as CEO, company reports 48% revenue growth - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

PROCEPT BioRobotics Achieves 48% Revenue Surge to $79.2M as Edwards Lifesciences Veteran Takes CEO Role - Stock Titan

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about PROCEPT BioRobotics Corporation stockRapid wealth accumulation - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Is PROCEPT BioRobotics Corporation stock a growth or value playFree Trend-Following Techniques - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives PROCEPT BioRobotics Corporation stock priceRapid-fire capital growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

Redefining Prostate Cancer Care: How PROCEPT BioRobotics' Aquablation Therapy Could Disrupt Urology and Unlock a $10B+ Market - AInvest

Jul 23, 2025
pulisher
Jul 22, 2025

PROCEPT BioRobotics Corporation Stock Analysis and ForecastBreakthrough stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is PROCEPT BioRobotics Corporation a good long term investmentMassive portfolio appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Evaluating PROCEPT BioRobotics (PRCT) Ahead of Q2 2025 Earnings: A Strategic Buy Opportunity in Surgical Robotics? - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Procept Biorobotics shares rise 1.65% after-hours after announcing Q2 2025 earnings report date. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025 - The Manila Times

Jul 21, 2025
pulisher
Jul 21, 2025

PROCEPT BioRobotics to Announce Second Quarter 2025 Financial Results on August 6, 2025 - Quiver Quantitative

Jul 21, 2025
pulisher
Jul 21, 2025

PROCEPT BioRobotics Corp (PRCT) stock falls 3.23% on July 21 - AInvest

Jul 21, 2025
pulisher
Jul 20, 2025

PROCEPT BioRobotics Corp Shares Surge 3.68% Amid Analyst Predictions of 26.35% Upside - AInvest

Jul 20, 2025
pulisher
Jul 19, 2025

Nisa Investment Advisors LLC Purchases 270 Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

Why PROCEPT BioRobotics Corporation stock is on top investor watchlistsExpert Trading Flow - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

how procept biorobotics corporation stock performs during market volatilityGroup Only Stock Signals - Newser

Jul 17, 2025
pulisher
Jul 17, 2025

Morgan Stanley Lowers PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $68.00 - Defense World

Jul 17, 2025
pulisher
Jul 17, 2025

Q2 EPS Estimate for PROCEPT BioRobotics Raised by Analyst - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

Positive Outlook on PROCEPT BioRobotics Amid New Fee Schedule Developments for Aquablation - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Procept BioRobotics Receives Favorable CMS Updates and Reimbursement Stability - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Procept BioRobotics says Aquablation therapy assigned a Category I code - MSN

Jul 16, 2025
pulisher
Jul 16, 2025

A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $68 to $85 - 富途牛牛

Jul 16, 2025
pulisher
Jul 16, 2025

Teacher Retirement System of Texas Has $646,000 Stock Holdings in PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

PROCEPT BioRobotics (NASDAQ:PRCT) Shares Down 4.7% Following Analyst Downgrade - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

How PROCEPT BioRobotics Corporation stock performs during market volatilityFree Smart Money Stock Analysis - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why PROCEPT BioRobotics Corporation stock attracts strong analyst attentionPredictable Return Stock Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes PROCEPT BioRobotics Corporation stock price move sharplyFree Real-Time Trading Opportunities - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Procept BioRobotics Awarded Category 1 Code in 2026 Medicare Proposal - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Procept BioRobotics stock maintains Buy rating at BofA despite Medicare cuts By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Procept BioRobotics stock maintains Buy rating at BofA despite Medicare cuts - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 14, 2025

Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule - Stock Titan

Jul 14, 2025
pulisher
Jul 14, 2025

Buy Recommendation for Procept BioRobotics Supported by Favorable CMS Updates and Reimbursement Stability - TipRanks

Jul 14, 2025

Procept Biorobotics Corp Azioni (PRCT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$286.58
price down icon 0.03%
medical_devices STE
$227.25
price up icon 0.79%
medical_devices PHG
$25.84
price down icon 0.04%
$86.74
price up icon 0.36%
$76.77
price down icon 0.62%
medical_devices EW
$75.80
price down icon 1.44%
Capitalizzazione:     |  Volume (24 ore):